The following grid describes the evaluation and disposition for specified PRP utilization. Results are approval after RN review, referral for physician review, or investigational/experimental. Any utilization not listed requires physician review.
Achilles tendinopathy: Investigational/experimental. Randomized trials cited by the guideline failed to show superiority of PRP over placebo or physiotherapy.
Achilles rupture: Investigational/experimental. The guideline states that surgical treatment is required for Achilles tendon rupture.
Ankle osteoarthritis injections: The grid contains both an approval-after-RN-review marker and an investigational/experimental marker. Supporting information cites a 2021 randomized trial showing no significant improvement versus placebo, while other small studies reported positive findings with important limitations.
Source table contains conflicting disposition markers; preserve for physician interpretation.
Anterior cruciate ligament injury or reconstruction, nonsurgical: Approve after RN review when the request is for injection without surgery; the guideline cites two studies with positive results. Intraoperative or surgical ACL reconstruction use is investigational/experimental because systematic reviews found no beneficial clinical, graft-integration, or tunnel-enlargement outcomes.
Separate nonsurgical injection from surgical or intraoperative reconstruction use.
Patellar tendon ACL reconstruction donor site: Approve after RN review for surgical application at the patellar tendon harvest site; cited studies reported improved healing and pain.
Knee osteoarthritis injections: Investigational/experimental. The RESTORE randomized clinical trial cited in the guideline found no significant difference from saline placebo in symptoms or joint structure at 12 months.
Lateral epicondylitis: Disposition depends on PRP formulation: leukocyte-rich PRP is marked for approval after RN review, while use without leukocyte-rich PRP requires physician review. The guideline describes inconsistent and contradictory evidence overall.
Confirm whether the request involves leukocyte-rich PRP.
Meniscal tears: Investigational/experimental. The guideline cites few, small, and contradictory studies.
Muscle injury: Refer for physician review. Evidence includes non-randomized studies suggesting improved tissue repair or functional recovery, but randomized trials showed controversial results.
Patellar tendinopathy: Refer for physician review and identified as investigational/experimental in the grid. Evidence is described as minimal and conflicting, although one meta-analysis was highly positive for leukocyte-rich PRP.
The grid contains both physician-review and investigational/experimental markers.
Plantar fasciitis: The grid contains both an approval-after-RN-review marker and an investigational/experimental marker. Evidence is conflicting, generally low quality, and shows marginal or limited benefit.
Source table contains conflicting disposition markers; preserve for physician interpretation.
Rotator cuff injuries: Investigational/experimental is marked for the overall rotator cuff category. Supporting discussion describes PRP as a possible conservative alternative to corticosteroid injection for tendinopathy and partial tears; the source table distinguishes tendinopathy or partial tears from other tears.
Confirm tear type and treatment context.
Ulnar collateral ligament injury: Approve after RN review. Three small studies in athletes reported improved outcomes.